Navigation Links
Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization
Date:5/20/2008

Through its affiliations, Novation represents 49 percent of admissions and

52 percent of total surgeries in the United States

SUNNYVALE, Calif., May 20 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced it has signed a contract with Novation, the industry's leading contracting services company serving VHA Inc., University HealthSystem Consortium (UHC) and Provista, LLC. Through its affiliations, Novation represents 49 percent of admissions, 52 percent of total surgeries and 44 percent of staffed beds in the United States. Under the terms of the contract, VHA, UHC and Provista members can take advantage of Cepheid's GeneXpert(R) System and Xpert(TM) MRSA tests at pre-negotiated prices.

"Institutions accessing Novation contracts are recognizing that active surveillance, with rapid turnaround time, is a key component of a comprehensive infection control program," said Rob Koska, Cepheid's Senior Vice President of Worldwide Commercial Operations. "We look forward to working with these institutions as they deploy the most rapid and effective surveillance testing technology in the industry."

MRSA is recognized as a growing public health concern, cited as a leading cause of Healthcare Acquired Infections (HAIs). Infection rates have increased every year since 1970. Xpert MRSA test results are currently available in approximately 70 minutes, thereby enabling rapid identification of carriers of the pathogen in less than 2 hours from the time of patient sampling to the delivery of test results to the floor. The availability of the Xpert MRSA test and the GeneXpert System is expected to enable Novation hospitals to implement more efficient infection control measures, leading to lower HAI rates and improved patient care.

On-demand Xpert MRSA results enable healthcare professionals to rapidly identify MRSA colonized patients entering the hospital population, thereby reducing risk of potential transmission. As recent st
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
2. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
3. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
4. Cepheid Reports Fourth Quarter and Full Year 2007 Results
5. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
6. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
9. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
10. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
11. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...senting at BIO CEO & Investor Conference, LOUISVI... ) announced today that it will host a conference ... to report 2007 fourth quarter,and year-end earnin...oming,investor conference in February 2008., Ear... Kenneth J. Collins, President and CEO, and othe...
...SISSAUGA, ON, Feb. 5 /PRNewswire-FirstCall/ - Vaso... Company focused on the research and,commercial de...flammation,underlying cardiovascular and neurologi...resident and CEO, will present a Company Overview ...toria, New York City, at 11:00,a.m. (ET) on Tuesda...
...KVILLE, Md., Feb. 5 EntreMed, Inc.,(Nasdaq: ENMD...ing,therapeutics for the treatment of cancer and i.... Burns, President and Chief Executive Officer, wi... Investor Conference, to be,held at the Waldorf-As...ntation is scheduled for Tuesday, February 12, 200...
Other Biology Technology:Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel 2Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel 3EntreMed to Present at BIO CEO and Investor Conference 2
(Date:11/24/2009)...stallised a protein that may help gut bacteria bin... be used by probiotic producers to identify strain... , "Probiotics need to interact with cells lining...attach to surfaces in the gut they are more likely...ty," says Dr Nathalie Juge from the Institute of F...
(Date:11/24/2009)...erican College of Medical Toxicology (ACMT) have s...on of the Journal of Medical Toxicology (JMT), t...h 2010. It was previously published by the Univer...edical Toxicology , an international, peer-reviewe...nd practice of medical toxicology. The quarterly ...
(Date:11/24/2009)...ish food is a matter of debate. A high-profile stu...50 percent of their carbon from trees and leaves, ...rial and aquatic ecosystems. , But new research ...t likely to be true. Algae provide a much richer d...research published this week in the Proceedings o...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Terumo Heart Inc Wins Top Healthcare Category Honors at AnnArbor com 26apos 3Bs 5th Annual 26amp 3B 238216 3BDeals Of The Year 26apos 3B Award Cere 61603 1Terumo Heart Inc Wins Top Healthcare Category Honors at AnnArbor com 26apos 3Bs 5th Annual 26amp 3B 238216 3BDeals Of The Year 26apos 3B Award Cere 61603 2Terumo Heart Inc Wins Top Healthcare Category Honors at AnnArbor com 26apos 3Bs 5th Annual 26amp 3B 238216 3BDeals Of The Year 26apos 3B Award Cere 61603 3Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction Inc 61599 1Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction Inc 61599 2Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction Inc 61599 3Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 1Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 2Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 3Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 4
..., Nitrogen pollution from agriculture and fossil ... in the UK. A new European study is starting to sh... current policies to protect ecosystems may need a...in 2004, her findings were so significant they wer...elected as contributing to one of the top ten scie...
..., Athens, Ga. For the estimated millions of AIDS...oping resistance to currently available medicines,... may offer a new treatment option by targeting a p... responsible for the devastating disease. , Appr...ectious viral disease known as HIV-AIDS. Although ...
..., WALNUT CREEK, -The genome analysis of a tiny gr...uniquely associated with carbon dioxide capture an...es revealed in the study are those that encode the...le that houses the photosynthetic apparatus, the c...ght to chemical energy. The genome also provides ...
Other Biology News:Nitrogen -- the silent species eliminator 2Nitrogen -- the silent species eliminator 3New class of drug offers hope to treatment-resistant AIDS patients 2New class of drug offers hope to treatment-resistant AIDS patients 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3
Sheep Anti-Pig Malate Dehydrogenase Polyclonal Antibody, Unconjugated from Abcam
TaqMan Rodent GAPDH Control Reagents from Applied Biosystems
Anti-Sodium Channel, NaB2 (B2 subunit of Voltate-Gated Na+ Channel, Scn2b) Polyclonal Antibody, Unconjugated from CHEMICON
Chicken Anti-HAGH Polyclonal Antibody, Unconjugated from Abcam
Biology Products: